INS and polycystic ovary syndrome: However, we have shown that differences in several parameters persisted after the adjustment for a decrease of > 5% or >10% of body weight thus suggesting that the drug combination used displays an improvement in the insulin sensitivity and can attenuate the central and total body adiposity of young PCOS women.